Follow-Up Study of Hormones, Interlukines, Total Antioxidant Capacity, and Oxidative Stress in Sleeve Gastrectomy
DOI:
https://doi.org/10.51699/cajmns.v7i3.3313Keywords:
Sleeve Gastrectomy, ghrelin, leptin, T-AOc, TOS, IL-17, IL34Abstract
This prospective follow-up study was designed to evaluate the metabolic changes in patients undergoing gastric sleeve surgery. The results reported a substantial improvement at (p ≤ 0.05) in the level of T-AOC in the G3 (after 8 months) when compared with G1 (after 3 months) and G2 (after 6 months). A considerable diminution at (p ≤ 0.05) in the level of TOS was also detected in the third group versus G1and G2 groups. Moreover, the levels of appetite regulating hormones, including ghrelin and leptin showed a significant decrease at (p ≤ 0.05) in the levels of these hormones in G3 group when compared with the G1and G2 groups. These data imply a progressive, time- dependent improvement in redox balance and hormonal variation in patients over time following sleeve gastrectomy.
References
R. Barazzoni, G. Gortan Cappellari, M. Ragni, and E. Nisoli, “INSULIN RESISTANCE IN OBESITY-An overview of fundamental alterations.”
E. Martínez-Martínez and V. Cachofeiro, “Oxidative Stress in Obesity,” Apr. 01, 2022, MDPI. doi: 10.3390/antiox11040639.
S. Furukawa et al., “Increased oxidative stress in obesity and its impact on metabolic syndrome,” J. Clin. Invest., vol. 114, no. 12, pp. 1752–1761, 2017.
T. D. Müller et al., “Ghrelin,” Mol. Metab., vol. 4, no. 6, pp. 437–460, Jun. 2015, doi: 10.1016/J.MOLMET.2015.03.005.
J. Nijhuis, F. M. H. van Dielen, W. A. Buurman, and J. W. M. Greve, “Ghrelin, Leptin and Insulin Levels after Restrictive Surgery: a 2-Year Follow-up Study,” Obes. Surg., vol. 14, no. 6, pp. 783–787, Jun. 2004, doi: 10.1381/0960892041590980.
P. Kalinowski et al., “Ghrelin, leptin, and glycemic control after sleeve gastrectomy versus Roux-en-Y gastric bypass—results of a randomized clinical trial,” Surgery for Obesity and Related Diseases, vol. 13, no. 2, pp. 181–188, Feb. 2017, doi: 10.1016/J.SOARD.2016.08.025.
L. A. Zúñiga et al., “IL-17 regulates adipogenesis, glucose homeostasis, and obesity,” The Journal of Immunology, vol. 185, no. 11, pp. 6947–6959, 2010.
J. Shang, Y. Xu, S. Pu, X. Sun, and X. Gao, “Role of IL-34 and its receptors in inflammatory diseases,” Cytokine, vol. 171, p. 156348, Nov. 2023, doi: 10.1016/J.CYTO.2023.156348.
E. Colak and D. Pap, “The role of oxidative stress in the development of obesity and obesity-related metabolic disorders,” 2021, Society of Medical Biochemists of Serbia. doi: 10.5937/jomb0-24652.
A. Azlan, S. Sultana, C. S. Huei, and M. R. Razman, “Antioxidant, Anti-Obesity, Nutritional and Other Beneficial Effects of Different Chili Pepper: A Review,” Feb. 01, 2022, MDPI. doi: 10.3390/molecules27030898.
K. Fay and A. Patel, “Bariatric Surgery,” in Anatomic, Physiologic, and Therapeutic Principles of Surgical Diseases, Cham: Springer International Publishing, 2023, pp. 173–189. doi: 10.1007/978-3-031-25596-0_12.
O. Bulur et al., “Nutritional and hematological changes after sleeve gastrectomy,” Rom. J. Diabetes Nutr. Metab. Dis., vol. 28, no. 4, pp. 343–351, 2021.
X. Terra et al., “Long-term Changes in Leptin, Chemerin and Ghrelin Levels Following Different Bariatric Surgery Procedures: Roux-en-Y Gastric Bypass and Sleeve Gastrectomy,” Obes. Surg., vol. 23, no. 11, pp. 1790–1798, Nov. 2013, doi: 10.1007/s11695-013-1033-9.
S. Şimşek, B. E. R. URGANCI, S. Yilmaz, M. R. Aykota, T. Sari, and İ. AÇIKBAŞ, “One-year follow-up of the oxidative stress profile of patients after laparoscopic sleeve gastrectomy.,” Eur. Rev. Med. Pharmacol. Sci., vol. 27, no. 21, 2023.
T. Min, S. L. Prior, G. Dunseath, R. Churm, J. D. Barry, and J. W. Stephens, “Temporal Effects of Bariatric Surgery on Adipokines, Inflammation and Oxidative Stress in Subjects with Impaired Glucose Homeostasis at 4 Years of Follow-up,” Obes. Surg., vol. 30, no. 5, pp. 1712–1718, May 2020, doi: 10.1007/s11695-019-04377-3.
M. M. A. Abulmeaty et al., “Inflammatory Cytokines, Redox Status, and Cardiovascular Diseases Risk after Weight Loss via Bariatric Surgery and Lifestyle Intervention,” Medicina (B. Aires)., vol. 59, no. 4, p. 751, Apr. 2023, doi: 10.3390/medicina59040751.
G. de Souza Bett et al., “Bariatric Surgery Reduces Lipid Profile and Oxidative Stress in Patients With Obesity: A Prospective Cohort Study,” Journal of Metabolic and Bariatric Surgery, vol. 14, no. 1, p. 32, 2025, doi: 10.17476/jmbs.2025.14.1.32.
aniar Ghazizadeh et al., “Definition of an oxidative stress status by combined assessment of Malondialdehyde and Oxidized-LDL: A study in patients with type2 diabetes and control,” Meta Gene, vol. 19, 2019, doi: 10.1016/j.mgene.2018.10.005.
J. Gutiérrez-Hellín et al., “Research Trends in the Effect of Caffeine Intake on Fat Oxidation: A Bibliometric and Visual Analysis,” Nutrients, vol. 15, no. 20, p. 4320, Oct. 2023, doi: 10.3390/nu15204320.
A. Metere, C. E. Graves, D. Pietraforte, and G. Casella, “The Effect of Sleeve Gastrectomy on Oxidative Stress in Obesity,” Biomedicines, vol. 8, no. 6, p. 168, Jun. 2020, doi: 10.3390/biomedicines8060168.
M. M. Bayliak, O. B. Abrat, J. M. Storey, K. B. Storey, and V. I. Lushchak, “Interplay between diet-induced obesity and oxidative stress: Comparison between Drosophila and mammals,” Comp. Biochem. Physiol. A Mol. Integr. Physiol., vol. 228, pp. 18–28, Feb. 2019, doi: 10.1016/J.CBPA.2018.09.027.
P. Chaudhary et al., “Oxidative stress, free radicals and antioxidants: potential crosstalk in the pathophysiology of human diseases,” Front. Chem., vol. 11, May 2023, doi: 10.3389/fchem.2023.1158198.
F. B. Langer et al., “Sleeve Gastrectomy and Gastric Banding: Effects on Plasma Ghrelin Levels,” Obes. Surg., vol. 15, no. 7, pp. 1024–1029, Aug. 2005, doi: 10.1381/0960892054621125.
G. Sharma, P. S. Nain, P. Sethi, A. Ahuja, and S. Sharma, “Plasma ghrelin levels after laparoscopic sleeve gastrectomy in obese individuals,” Indian Journal of Medical Research, vol. 149, no. 4, pp. 544–547, Apr. 2019, doi: 10.4103/ijmr.IJMR_984_18.
P. Kalinowski et al., “Ghrelin, leptin, and glycemic control after sleeve gastrectomy versus Roux-en-Y gastric bypass—results of a randomized clinical trial,” Surgery for Obesity and Related Diseases, vol. 13, no. 2, pp. 181–188, Feb. 2017, doi: 10.1016/j.soard.2016.08.025.
X. Terra et al., “Long-term Changes in Leptin, Chemerin and Ghrelin Levels Following Different Bariatric Surgery Procedures: Roux-en-Y Gastric Bypass and Sleeve Gastrectomy,” Obes. Surg., vol. 23, no. 11, pp. 1790–1798, Nov. 2013, doi: 10.1007/s11695-013-1033-9.
M. Salman, K. Noureldin, M. Issa, H. Agwa, M. G. Fadlallah Elhaj, and A. Shalaby, “ThTP2.4 Long-Term Changes in Leptin, Chemerin, and Ghrelin Levels Following Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy,” British Journal of Surgery, vol. 110, no. Supplement_6, Aug. 2023, doi: 10.1093/bjs/znad241.255.
M. L. Alosco et al., “Improved Serum Leptin and Ghrelin Following Bariatric Surgery Predict Better Postoperative Cognitive Function,” Journal of Clinical Neurology, vol. 11, no. 1, p. 48, 2015, doi: 10.3988/jcn.2015.11.1.48.
M. Bužga et al., “Dietary intake and ghrelin and leptin changes after sleeve gastrectomy.,” Wideochir. Inne Tech. Maloinwazyjne., vol. 9, no. 4, pp. 554–61, Dec. 2014, doi: 10.5114/wiitm.2014.45437.
F. Turkoglu et al., “Effect of bariatric surgery procedures on serum cytokine and Nesfatin-1 levels,” The Surgeon, vol. 21, no. 5, pp. e287–e291, Oct. 2023, doi: 10.1016/j.surge.2023.03.002.
K. Zorena, O. Jachimowicz-Duda, D. Ślęzak, M. Robakowska, and M. Mrugacz, “Adipokines and obesity. Potential link to metabolic disorders and chronic complications,” Int. J. Mol. Sci., vol. 21, no. 10, p. 3570, 2020.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Noorhan Entidhar Kadhim , Ali Noory Fajer

This work is licensed under a Creative Commons Attribution 4.0 International License.